HLA-A and diffuse large B-cell lymphoma: Immune editing and evasion of immune surveillance is a hallmark of the DLBCL, especially the MCD subtype and therefore the ABC type, with 76% of MCD acquiring mutation or deletion of HLA-A, HLA-B, or HLA-C (Chang et al., 2016).